Table of Content

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. DECONGESTION NASAL SPRAY HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCT
3.2.2. OVER THE COUNTER PRESCRIPTION IS ANTICIPATED TO GROW SIGNIFICANTLY
3.2.3. ANTIHISTAMINE IS THE FASTEST GROWING THERAPEUTICS
3.2.4. NASAL CONGESTION IS THE MAJORLY USED APPLICATION OF NASAL SPRAY DEVICES
3.2.5. HOME CARE SETTING IS THE FASTEST GROWING END-USER

4. MARKET DETERMINANTS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. SURGE IN INCIDENCE OF RESPIRATORY DISEASES
4.2.2. LOW COST OF GENERIC PRESCRIPTION DRUGS
4.3. MARKET RESTRAINTS
4.3.1. STRINGENT REGULATION
4.3.2. RISING INCIDENCES OF PRODUCT RECALL
4.4. MARKET OPPORTUNITIES
4.4.1. RISING ADOPTION OF GENERIC DRUGS
4.4.2. GROWING DEMAND OF NASAL DRUGS IN PHARMACEUTICAL MARKET
4.5. MARKET CHALLENGES
4.5.1. PATENT EXPIRATION

5. MARKET BY PRODUCT
5.1. DECONGESTION NASAL SPRAY
5.2. SALTWATER SOLUTION/ SALINE NASAL SPRAY
5.3. STEROID NASAL SPRAY

6. MARKET BY PRESCRIPTION
6.1. OVER-THE-COUNTER
6.2. PRESCRIBED

7. MARKET BY THERAPEUTIC
7.1. ANTIHISTAMINE
7.2. ANTICHOLINERGIC
7.3. MAST CELL INHIBITOR
7.4. NASAL STEROIDS

8. MARKET BY APPLICATION
8.1. ALLERGIC AND NON-ALLERGIC RHINITIS
8.2. CNS DISORDERS
8.3. NASAL CONGESTION
8.4. VACCINATION
8.5. OTHER APPLICATION

9. MARKET BY END-USER
9.1. ASC/CLINICS
9.2. HOME CARE SETTING
9.3. HOSPITAL
9.4. PHARMACY
9.5. OTHER END-USER

10. KEY ANALYTICS
10.1. PORTER’S FIVE FORCES MODEL
10.1.1. THREAT OF NEW ENTRANTS
10.1.2. THREAT OF SUBSTITUTE
10.1.3. BARGAINING POWER OF BUYERS
10.1.4. BARGAINING POWER OF SUPPLIERS
10.1.5. THREAT OF COMPETITIVE RIVALRY
10.2. KEY BUYING CRITERIA
10.3. SUPPLY CHAIN ANALYSIS
10.4. REGULATORY FRAMEWORK
10.5. OPPORTUNITY MATRIX

11. GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1. THE UNITED STATES
11.1.2. CANADA

12. COMPETITIVE LANDSCAPE
12.1. MARKET SHARE ANALYSIS
12.2. COMPANY PROFILES
12.2.1. ADAPT PHARMA, INC. (ACQUIRED BY EMERGENT BIOSOLUTIONS)
12.2.1.1. COMPANY OVERVIEW
12.2.1.2. PRODUCT LAUNCH
12.2.1.3. STRATEGIC INITIATIVES
12.2.2. ALLERGAN INC.
12.2.2.1. COMPANY OVERVIEW
12.2.2.2. PRODUCT & SERVICES
12.2.2.3. SCOT ANALYSIS
12.2.2.4. STRATEGIC INITIATIVES
12.2.3. APOTEX
12.2.3.1. COMPANY OVERVIEW
12.2.3.2. PRODUCT PORTFOLIO
12.2.3.3. STRATEGIC INITIATIVES
12.2.4. BECTON DICKINSON AND COMPANY
12.2.4.1. COMPANY OVERVIEW
12.2.4.2. PRODUCT PORTFOLIO
12.2.4.3. SCOT ANALYSIS
12.2.4.4. STRATEGIC INITIATIVES
12.2.5. BEXIMCO PHARMACEUTICALS
12.2.5.1. COMPANY OVERVIEW
12.2.5.2. PRODUCT LAUNCH
12.2.5.3. STRATEGIC INITIATIVES
12.2.6. CIPLA
12.2.6.1. COMPANY OVERVIEW
12.2.6.2. PRODUCT PORTFOLIO
12.2.6.3. SCOT ANALYSIS
12.2.6.4. STRATEGIC INITIATIVES
12.2.7. GLAXOSMITHKLINE
12.2.7.1. COMPANY OVERVIEW
12.2.7.2. PRODUCT PORTFOLIO
12.2.7.3. SCOT ANALYSIS
12.2.7.4. STRATEGIC INITIATIVES
12.2.8. HIKMA PHARMACEUTICALS PLC
12.2.8.1. COMPANY OVERVIEW
12.2.8.2. PRODUCT PORTFOLIO
12.2.8.3. STRATEGIC INITIATIVES
12.2.9. MERCK & CO., INC.
12.2.9.1. COMPANY PROFILES
12.2.9.2. PRODUCT PORTFOLIO
12.2.9.3. SCOT ANALYSIS
12.2.9.4. STRATEGIC INITIATIVES
12.2.10. MYLAN NV
12.2.10.1. COMPANY OVERVIEW
12.2.10.2. PRODUCT PORTFOLIO
12.2.10.3. STRATEGIC INITIATIVES
12.2.11. PFIZER, INC.
12.2.11.1. COMPANY PROFILES
12.2.11.2. PRODUCT PORTFOLIO
12.2.11.3. SCOT ANALYSIS
12.2.11.4. STRATEGIC INITIATIVES
12.2.12. SANDOZ INTERNATIONAL GMBH (SUBSIDIARY OF NOVARTIS AG)
12.2.12.1. COMPANY OVERVIEW
12.2.12.2. PRODUCT PORTFOLIO
12.2.12.3. STRATEGIC INITIATIVES
12.2.13. SANOFI-AVENTIS S.A.
12.2.13.1. COMPANY OVERVIEW
12.2.13.2. PRODUCT PORTFOLIO
12.2.13.3. SCOT ANALYSIS
12.2.13.4. STRATEGIC INITIATIVES
12.2.14. SUN PHARMACEUTICALS INDUSTRIES, LTD.
12.2.14.1. COMPANY OVERVIEW
12.2.14.2. PRODUCT PORTFOLIO
12.2.14.3. SCOT ANALYSIS
12.2.14.4. STRATEGIC INITIATIVE
12.2.15. TEVA PHARMACEUTICAL INDUSTRIES, LTD.
12.2.15.1. COMPANY OVERVIEW
12.2.15.2. PRODUCT PORTFOLIO
12.2.15.3. STRATEGIC INITIATIVES


TABLE LIST
TABLE 1 NORTH AMERICA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 2 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY PRODUCT 2019-2027 ($ MILLION)
TABLE 3 NORTH AMERICA DECONGESTION NASAL SPRAY MARKET 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA SALT WATER SOLUTION/ SALINE NASAL SPRAY MARKET 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA STEROID NASAL SPRAY MARKET 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY PRESCRIPTION 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA OVER THE COUNTER MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA PRESCRIBED MARKET 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY THERAPEUTIC 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA ANTIHISTAMINE MARKET 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA ANTICHOLINERGIC MARKET 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA MAST CELL INHIBITOR MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA NASAL STEROIDS MARKET 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA ALLERGIC AND NON-ALLERGIC RHINITIS MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA CNS DISORDERS MARKET 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA NASAL CONGESTION MARKET 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA VACCINATION MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 20 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 21 NORTH AMERICA ASC/CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 22 NORTH AMERICA HOME CARE SETTING MARKET 2019-2027 ($ MILLION)
TABLE 23 NORTH AMERICA HOSPITAL MARKET 2019-2027 ($ MILLION)
TABLE 24 NORTH AMERICA PHARMACY MARKET 2019-2027 ($ MILLION)
TABLE 25 NORTH AMERICA OTHER END-USER MARKET 2019-2027 ($ MILLION)
TABLE 26 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)



FIGURES LIST
FIGURE 1 NORTH AMERICA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 2 NORTH AMERICA NASAL SPRAY DEVICES MARKET SHARE BY PRODUCT 2018 & 2027 (%)
FIGURE 3 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY DECONGESTION NASAL SPRAY 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY SALT WATER SOLUTION/ SALINE NASAL SPRAY 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY STEROID NASAL SPRAY 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA NASAL SPRAY DEVICES MARKET SHARE BY PRESCRIPTION 2018 & 2027 (%)
FIGURE 7 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY OVER THE COUNTER 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY PRESCRIBED 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA NASAL SPRAY DEVICES MARKET SHARE BY THERAPEUTIC 2018 & 2027 (%)
FIGURE 10 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY ANTIHISTAMINE 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY ANTICHOLINERGIC 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY MAST CELL INHIBITOR 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY NASAL STEROIDS 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA NASAL SPRAY DEVICES MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 15 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY ALLERGIC AND NON-ALLERGIC RHINITIS 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY CNS DISORDERS 2019-2027 ($ MILLION)
FIGURE 17 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY NASAL CONGESTION 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY VACCINATION 2019-2027 ($ MILLION)
FIGURE 19 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 20 NORTH AMERICA NASAL SPRAY DEVICES MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 21 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY ASC/CLINICS 2019-2027 ($ MILLION)
FIGURE 22 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY HOME CARE SETTING 2019-2027 ($ MILLION)
FIGURE 23 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY HOSPITAL 2019-2027 ($ MILLION)
FIGURE 24 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY PHARMACY 2019-2027 ($ MILLION)
FIGURE 25 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 26 PORTER’S FIVE FORCE MODEL
FIGURE 27 KEY BUYING CRITERIA
FIGURE 28 NORTH AMERICA NASAL SPRAY DEVICES SUPPLY CHAIN ANALYSIS
FIGURE 29 NORTH AMERICA NASAL SPRAY DEVICES MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 30 THE UNITED STATES NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 31 CANADA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 32 NASAL SPRAY DEVICES COMPANY MARKET SHARE 2017 (%)
 



List of Figures


FIGURES LIST
FIGURE 1 NORTH AMERICA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 2 NORTH AMERICA NASAL SPRAY DEVICES MARKET SHARE BY PRODUCT 2018 & 2027 (%)
FIGURE 3 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY DECONGESTION NASAL SPRAY 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY SALT WATER SOLUTION/ SALINE NASAL SPRAY 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY STEROID NASAL SPRAY 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA NASAL SPRAY DEVICES MARKET SHARE BY PRESCRIPTION 2018 & 2027 (%)
FIGURE 7 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY OVER THE COUNTER 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY PRESCRIBED 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA NASAL SPRAY DEVICES MARKET SHARE BY THERAPEUTIC 2018 & 2027 (%)
FIGURE 10 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY ANTIHISTAMINE 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY ANTICHOLINERGIC 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY MAST CELL INHIBITOR 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY NASAL STEROIDS 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA NASAL SPRAY DEVICES MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 15 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY ALLERGIC AND NON-ALLERGIC RHINITIS 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY CNS DISORDERS 2019-2027 ($ MILLION)
FIGURE 17 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY NASAL CONGESTION 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY VACCINATION 2019-2027 ($ MILLION)
FIGURE 19 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 20 NORTH AMERICA NASAL SPRAY DEVICES MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 21 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY ASC/CLINICS 2019-2027 ($ MILLION)
FIGURE 22 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY HOME CARE SETTING 2019-2027 ($ MILLION)
FIGURE 23 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY HOSPITAL 2019-2027 ($ MILLION)
FIGURE 24 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY PHARMACY 2019-2027 ($ MILLION)
FIGURE 25 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 26 PORTER’S FIVE FORCE MODEL
FIGURE 27 KEY BUYING CRITERIA
FIGURE 28 NORTH AMERICA NASAL SPRAY DEVICES SUPPLY CHAIN ANALYSIS
FIGURE 29 NORTH AMERICA NASAL SPRAY DEVICES MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 30 THE UNITED STATES NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 31 CANADA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 32 NASAL SPRAY DEVICES COMPANY MARKET SHARE 2017 (%)

 

List of Tables


TABLE LIST
TABLE 1 NORTH AMERICA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 2 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY PRODUCT 2019-2027 ($ MILLION)
TABLE 3 NORTH AMERICA DECONGESTION NASAL SPRAY MARKET 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA SALT WATER SOLUTION/ SALINE NASAL SPRAY MARKET 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA STEROID NASAL SPRAY MARKET 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY PRESCRIPTION 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA OVER THE COUNTER MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA PRESCRIBED MARKET 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY THERAPEUTIC 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA ANTIHISTAMINE MARKET 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA ANTICHOLINERGIC MARKET 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA MAST CELL INHIBITOR MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA NASAL STEROIDS MARKET 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA ALLERGIC AND NON-ALLERGIC RHINITIS MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA CNS DISORDERS MARKET 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA NASAL CONGESTION MARKET 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA VACCINATION MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 20 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 21 NORTH AMERICA ASC/CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 22 NORTH AMERICA HOME CARE SETTING MARKET 2019-2027 ($ MILLION)
TABLE 23 NORTH AMERICA HOSPITAL MARKET 2019-2027 ($ MILLION)
TABLE 24 NORTH AMERICA PHARMACY MARKET 2019-2027 ($ MILLION)
TABLE 25 NORTH AMERICA OTHER END-USER MARKET 2019-2027 ($ MILLION)
TABLE 26 NORTH AMERICA NASAL SPRAY DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)